Use of biomarkers to guide immunotherapy drug development
VentiRx, the developers of motolimod, a TLR8 agonist, have published preclinical and clinical results that indicate effective immune system stimulatio...
Pharmacodynamic biomarkers for Apremilast treatment in psoriatic arthritis
A new paper from Peter Schafer, et al, of Celgene shows how biomarkers can be used to monitor treatment response in an inflammatory disease setting. T...
Biomarker signatures predict clinical outcomes in metastatic colorectal cancer (mCRC) patients treated with chemotherapy and cediranib
Researchers sought to explore biomarkers in pre- and on- treatment mCRC patients receiving chemotherapy with and without cediranib, in order to identi...
Biomarkers for a new cancer immunotherapy drug
This month's paper features the results of a Phase I study on a new cancer immunotherapy drug. VTX-2337 is a toll-like receptor 8 agonist, activating...
Tackling Cancer’s Heterogeneity
This article from GEN suggests tackling cancer's heterogeneity using a multipronged approach that includes current advancements in the detection of pr...
Recorded Webinar: Quantitative Profiling of the Intrinsic Pathway of Apoptosis in Tumor Tissue using Myriad RBM’s Multiplex ApoptosisMAP™
If you were unable to attend the webinar or would like to view the webinar again, a recorded version is now available for your convenience. View Recor...
Swedish universities identify a prognostic protein biomarker for bladder cancer
Research published in the British Journal of Cancer correlates membranous expression of PODXL in urothelial bladder cancer with unfavorable tumor char...